Virility Medical对 Morari Medical提起专利侵权诉讼-动脉网

Virility Medical Files Patent Infringement Lawsuit Against Morari Medical

CISION 等信源发布 2025-04-03 04:16



可切换为仅中文







HOD HASHARON,

霍德哈沙隆，

Israel

以色列

，

April 2, 2025

2025年4月2日

/PRNewswire/ -- Virility Medical Ltd. ('Virility Medical'), a leading innovator in the sexual health industry, filed a patent infringement lawsuit on

/PRNewswire/ -- Virility Medical Ltd.（“Virility Medical”），性健康行业的领先创新者，提起了一项专利侵权诉讼

March 18, 2025

2025年3月18日

, in

，在

the United States

美国

District Court for the District of

地区法院

Delaware

特拉华州

against Morari, Inc. (d/b/a. Morari Medical).

针对莫拉里公司（即莫拉里医疗）。

继续阅读

Virility Logo

Virility 标志

The complaint asserts that Morari's MOR product infringes three

投诉称，Morari的MOR产品侵犯了三项专利。

United States

美国

patents owned by Virility Medical relating to Virility Medical's innovative and FDA cleared,

Virility Medical 拥有的与其创新且经 FDA 认证的专利，

在

2 device (formerly known as vPatch, clearance number K223595). The complaint also seeks treble damages and a permanent injunction against the sale of the infringing MOR product.

2 台设备（前身为 vPatch，注册号 K223595）。该投诉还要求三倍赔偿，并对侵权的 MOR 产品实施永久禁售令。

Morari recently announced that it received clearance from the United States Food and Drug Administration ('FDA') to market the MOR product. As explained in the recently filed complaint, Morari's FDA submission asserted that the MOR product is 'substantially equivalent' to Virility Medical's own FDA cleared product.

莫拉里最近宣布，它已获得美国食品和药物管理局（“FDA”）的批准，可以将MOR产品推向市场。正如最近提交的投诉中所解释的那样，莫拉里的FDA提交文件声称MOR产品与Virility Medical自己的FDA核准产品“实质等同”。

Indeed, Morari's CEO, .

确实，莫拉里公司的首席执行官。

Jeff Bennett

杰夫·贝内特

, has explained that Morari 'leverage[ed]' Virility Medical's 'existing research and technology' in order to 'expedite [its] product's development and market entry.'

，已解释称，莫拉里“利用”了Virility Medical的“现有研究和技术”，以“加快[其]产品的开发和市场进入。”

The Virility Medical patents asserted in the complaint are U.S. Patent Nos. 10,773,072; 11,471,666; and 12,194,289. Virility Medical also owns additional patents and pending patent applications.

投诉中声称的Virility Medical专利是美国专利号10,773,072；11,471,666；和12,194,289。Virility Medical还拥有其他专利和正在申请的专利。

About Virility Medical

关于Virility Medical

Virility Medical is a consumer healthcare company specializing in sexual health and dedicated to enhancing sexual wellbeing. Virility Medical's patented technology, which is marketed under the brand name

Virility Medical是一家专注于性健康的消费者医疗保健公司，致力于提升性健康。Virility Medical的专利技术以品牌名称进行市场推广。

在

2, provides a drug-free treatment for premature ejaculation, one of the most common male sexual health concerns. The

2，提供了一种无需药物治疗早泄的方法，早泄是最常见的男性性健康问题之一。

在

2 device was subjected to clinical testing, resulting in marketing clearance from United States Food and Drug Administration, CE marking obtained for distribution in

2台设备接受了临床测试，从而获得了美国食品药品监督管理局的上市许可，并取得了CE标志，以便在

Europe

欧洲

under the MDR, and approval from the Israeli Ministry of Health.

根据MDR，并获得以色列卫生部的批准。

SOURCE Virility Medical Ltd.

来源：Virility Medical Ltd.

WANT YOUR COMPANY'S NEWS

想要你公司的新闻吗

FEATURED ON PRNEWSWIRE.COM?

刊登在PRNEWSWIRE.COM上？

440k+